DK609985D0 - Adhesin-antigener, antistoffer mod disse og dna-fragmenter, som indkoder antigenerne - Google Patents

Adhesin-antigener, antistoffer mod disse og dna-fragmenter, som indkoder antigenerne

Info

Publication number
DK609985D0
DK609985D0 DK609985A DK609985A DK609985D0 DK 609985 D0 DK609985 D0 DK 609985D0 DK 609985 A DK609985 A DK 609985A DK 609985 A DK609985 A DK 609985A DK 609985 D0 DK609985 D0 DK 609985D0
Authority
DK
Denmark
Prior art keywords
antigenes
adhesin
antibodies against
antigen
encod
Prior art date
Application number
DK609985A
Other languages
English (en)
Other versions
DK609985A (da
DK171258B1 (da
Inventor
Frederik Carl Peter Lindberg
Bjoern Olof Lund
Britt Monika Baaga
Mari Elisabet Norgren
Mikael Goeransson
Bernt Eric Anund Uhlin
Jan Staffan Normark
David Lee Lark
Original Assignee
Syn Tek Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syn Tek Ab filed Critical Syn Tek Ab
Priority to DK609985A priority Critical patent/DK171258B1/da
Publication of DK609985A publication Critical patent/DK609985A/da
Publication of DK609985D0 publication Critical patent/DK609985D0/da
Application granted granted Critical
Publication of DK171258B1 publication Critical patent/DK171258B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/82—Subcellular parts of microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK609985A 1984-05-02 1985-12-30 Antigent præparat indeholdende en determinant fra et adhesin-polypeptid, fremgangsmåder til fremstilling af deteminanten og adhesin-polypeptidet, anvendelser af determinanten og adhesin-polypeptidet, vaccine indeholdende determinanten, fremgangsmåde til fremstilling af vaccinen, antistof rettet mod determinanten, fremgangsmåde til fremstilling af antistoffet, præparatet til passiv immunisering DK171258B1 (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK609985A DK171258B1 (da) 1984-05-02 1985-12-30 Antigent præparat indeholdende en determinant fra et adhesin-polypeptid, fremgangsmåder til fremstilling af deteminanten og adhesin-polypeptidet, anvendelser af determinanten og adhesin-polypeptidet, vaccine indeholdende determinanten, fremgangsmåde til fremstilling af vaccinen, antistof rettet mod determinanten, fremgangsmåde til fremstilling af antistoffet, præparatet til passiv immunisering

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DK2190/84A DK219084D0 (da) 1984-05-02 1984-05-02 Antigen
DK219084 1984-05-02
DK8500045 1985-05-02
PCT/DK1985/000045 WO1985005037A1 (en) 1984-05-02 1985-05-02 Adhesin antigens, antibodies and dna fragment encoding the antigen, methods and means for diagnosis and immunization etc.
DK609985A DK171258B1 (da) 1984-05-02 1985-12-30 Antigent præparat indeholdende en determinant fra et adhesin-polypeptid, fremgangsmåder til fremstilling af deteminanten og adhesin-polypeptidet, anvendelser af determinanten og adhesin-polypeptidet, vaccine indeholdende determinanten, fremgangsmåde til fremstilling af vaccinen, antistof rettet mod determinanten, fremgangsmåde til fremstilling af antistoffet, præparatet til passiv immunisering
DK609985 1985-12-30

Publications (3)

Publication Number Publication Date
DK609985A DK609985A (da) 1985-12-30
DK609985D0 true DK609985D0 (da) 1985-12-30
DK171258B1 DK171258B1 (da) 1996-08-12

Family

ID=8110676

Family Applications (2)

Application Number Title Priority Date Filing Date
DK2190/84A DK219084D0 (da) 1984-02-02 1984-05-02 Antigen
DK609985A DK171258B1 (da) 1984-05-02 1985-12-30 Antigent præparat indeholdende en determinant fra et adhesin-polypeptid, fremgangsmåder til fremstilling af deteminanten og adhesin-polypeptidet, anvendelser af determinanten og adhesin-polypeptidet, vaccine indeholdende determinanten, fremgangsmåde til fremstilling af vaccinen, antistof rettet mod determinanten, fremgangsmåde til fremstilling af antistoffet, præparatet til passiv immunisering

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK2190/84A DK219084D0 (da) 1984-02-02 1984-05-02 Antigen

Country Status (13)

Country Link
US (3) US4795803A (da)
EP (1) EP0179887B1 (da)
JP (2) JP2974028B2 (da)
KR (1) KR950000688B1 (da)
AT (1) ATE91629T1 (da)
AU (1) AU593770B2 (da)
CA (1) CA1340847C (da)
DE (1) DE3587468T2 (da)
DK (2) DK219084D0 (da)
FI (1) FI93310C (da)
IE (1) IE59826B1 (da)
RU (1) RU1787165C (da)
WO (1) WO1985005037A1 (da)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4736017A (en) * 1984-04-30 1988-04-05 The Board Of Trustees Of The Leland Stanford Junior University Chemically defined vaccine against urinary infections
US4584195A (en) * 1984-06-21 1986-04-22 The Board Of Trustees Of The Leland Stanford Junior University Broad spectrum vaccine against gonorrhea
US4740585A (en) * 1984-07-30 1988-04-26 The Board Of Trustees Of The Leland Stanford Junior University Synthetic vaccine against urinary infections
US5288617A (en) * 1984-10-31 1994-02-22 Commonwealth Scientific And Industrial Research Organization Method of producing an antigenic preparation
AU590230B2 (en) * 1984-10-31 1989-11-02 Commonwealth Scientific And Industrial Research Organisation Improved antigenic preparation
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
EP0211352B1 (en) * 1985-08-01 1994-03-16 Miles Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4900659A (en) * 1986-01-30 1990-02-13 Enzo Biochem, Inc. Nucleotide sequence composition and method for detection of Neisseria gonorrhoeae and method for screening for a nucleotide sequence that is specific for a genetically distinct group
US4801690A (en) * 1986-03-24 1989-01-31 Bactex, Inc. Novel lectins derived from bacterial pili
SE8601940D0 (sv) * 1986-04-25 1986-04-25 Kabigen Ab Preparation of fused proteins, antibodies and processes therefor
US4786592A (en) * 1986-06-18 1988-11-22 Scripps Clinic And Research Foundation Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin
US7087742B1 (en) 1986-11-24 2006-08-08 Gen-Probe Incorporated Oligonucleotide probes for the detection and/or quantitation of non-viral organisms
US7090972B1 (en) 1986-11-24 2006-08-15 Gen-Probe Incorporated Methods for determining the presence of non-viral organisms in a sample
US5036003A (en) * 1987-08-21 1991-07-30 Monsanto Company Antibodies to VPF
AU601510B2 (en) * 1987-11-06 1990-09-13 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
SE8801894D0 (sv) * 1988-05-20 1988-05-20 Alfa Laval Agri Int Fibronektinbindande protein
US5055455A (en) 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
US7172863B1 (en) 1988-12-09 2007-02-06 Gen-Probe Incorporated Nucleic acid probes and methods for detecting Neisseria gonorrhoeae
CA1340530C (en) * 1989-04-28 1999-05-04 Kok Kheong Lee Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics
SE8901687D0 (sv) * 1989-05-11 1989-05-11 Alfa Laval Agri Int Fibronectin binding protein as well as its preparation
US5202113A (en) * 1990-04-30 1993-04-13 The United States Of America As Represented By The Department Of Health And Human Services Plaque-inhibiting protein from bacteroides loeschei and methods for using the same
ES2127198T3 (es) * 1990-08-02 1999-04-16 Antex Biolog Inc Receptores de adhesion para microorganismos patogenos u oportunistas.
US5440014A (en) * 1990-08-10 1995-08-08 H+E,Uml/Oo/ K; Magnus Fibronectin binding peptide
CA2098733A1 (en) * 1990-12-21 1992-06-22 Howard C. Krivan Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof
US5843463A (en) * 1990-12-21 1998-12-01 Antexbiologics, Inc. Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae
US5834591A (en) * 1991-01-31 1998-11-10 Washington University Polypeptides and antibodies useful for the diagnosis and treatment of pathogenic neisseria and other microorganisms having type 4 pilin
US5980908A (en) * 1991-12-05 1999-11-09 Alfa Laval Ab Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
AU662783B2 (en) * 1992-01-08 1995-09-14 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezonheid En Cultuur Whooping cough vaccine
EP1300156A3 (en) * 1993-05-18 2003-05-07 The Ohio State University Research Foundation Otitis media vaccine
US5648240A (en) * 1994-05-24 1997-07-15 Texas A&M University MHC II analog from Staphylococcus aureus
WO1996000233A1 (en) * 1994-06-24 1996-01-04 Children's Hospital And Medical Center Escherichia coli o157:h7 epithelial adhesin
DE19534579C2 (de) * 1995-09-18 2000-06-08 Max Planck Gesellschaft Nucleinsäure-Moleküle codierend Proteine, die die Adhäsion von Neisseria-Zellen an humane Zellen vermitteln
US6872398B2 (en) * 1995-12-22 2005-03-29 The United States Of America As Represented By The Secretary Of The Army Conjugate vaccine against gram-negative bacterial infections
NZ333250A (en) * 1996-06-10 2000-05-26 Thomas Boren Helicobacter pylori blood group antigen binding adhesion protein
AU1979599A (en) * 1998-01-14 1999-08-02 Chiron S.P.A. (neisseria meningitidis) antigens
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
US6692739B1 (en) 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
WO2000012132A1 (en) * 1998-08-31 2000-03-09 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US20040001863A1 (en) * 1998-12-03 2004-01-01 Shau-Chi Chi Immortal cell line derived from grouper Epinephelus coioides and its applications therein
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
WO2001045735A2 (en) * 1999-12-21 2001-06-28 Merial Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another enteric pathogen
MXPA03003690A (es) * 2000-10-27 2004-05-05 Chiron Spa Acidos nucleicos y proteinas de los grupos a y b de estreptococos.
ATE524195T1 (de) 2001-01-26 2011-09-15 Inhibitex Inc Monoklonale antikörper gegen das clfa-protein und verfahren zur verwendung bei der behandlung bzw. pr vention von infektionen
US7396822B2 (en) 2001-05-24 2008-07-08 Vaxiion Therapeutics, Inc. Immunogenic minicells and methods of use
US20030194798A1 (en) 2001-05-24 2003-10-16 Surber Mark W. Minicell compositions and methods
US7132101B2 (en) * 2002-02-27 2006-11-07 Duquesne University Of The Holy Ghost Compositions and methods for eliciting an immune response to gram-negative bacterial infections
AU2003256329A1 (en) * 2002-06-27 2004-01-19 University Of Washington Use of adhesion molecules as bond stress-enhanced nanoscale binding switches
WO2004043407A2 (en) * 2002-11-12 2004-05-27 The Brigham And Women's Hospital, Inc. Methods and products for treating staphylococcal infections
CA2501077C (en) 2002-11-12 2016-06-21 Gerald B. Pier Polysaccharide vaccine for staphylococcal infections
WO2006055024A2 (en) * 2004-04-05 2006-05-26 Vaxiion Therapeutics, Inc. Minicells as vaccines
AU2005236068C1 (en) 2004-04-21 2012-08-30 Beth Israel Deaconess Medical Center, Inc. Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof
US7585236B2 (en) * 2006-08-02 2009-09-08 Wilson Sporting Goods Co. Game ball having optimally positioned grooves and/or ridges
US8251846B2 (en) * 2006-08-02 2012-08-28 Wilson Sporting Goods Co. Game ball having optimally positioned grooves
US7686713B2 (en) * 2007-04-11 2010-03-30 Wilson Sporting Goods Co. Racquet stringing machine
CN101784655A (zh) * 2007-04-27 2010-07-21 菲尼克斯股份有限公司 可溶性重组二十面体病毒样颗粒的改良生成和体内装配
RU2532911C2 (ru) 2008-07-21 2014-11-20 Дзе Брихэм Энд Уимен'З Хоспитал, Инк. Способы и композиции, относящиеся к синтетическим бета-1,6-глюкозаминолигосахаридам
DK2675474T3 (da) 2011-02-15 2019-04-23 Vaxiion Therapeutics Llc Terapeutiske sammensætninger og fremgangsmåder til målrettet administration af bioaktive molekyler ved bak-terielle miniceller baseret på antistof og fc-holdige tar-geting-molekyler

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1332108B (en) 1908-12-21 1909-11-30 Improvements in means for transporting merchandise and other material in connection with the loading and unloading of vehicles
GB1472624A (en) * 1974-09-02 1977-05-04 Canadian Patents Dev Enteric disease vaccine
AU509621B2 (en) * 1975-04-25 1980-05-22 Dactex, Inc Detection, and'Prevention of Diseases caused by N, Gonorrhoeae
US4461838A (en) * 1975-04-25 1984-07-24 Bactex, Inc. Gonococcal Pili processes for the preparation thereof and the use thereof for the detection of and prevention of infections caused by Neisseria gonorrhoeae
GB1553664A (en) * 1975-06-12 1979-09-26 Unilever Ltd Antigenic compositions
US4136167A (en) * 1975-06-12 1979-01-23 Internationale Octrooi Maatschappij "Octropa" B.V. Process for reducing the incidence of neonatal diarrhoea in pigs
US4237115A (en) * 1977-11-23 1980-12-02 Bactex, Inc. Method of immunization against enterotoxogenic infection by Escherichia coli
US4336336A (en) * 1979-01-12 1982-06-22 President And Fellows Of Harvard College Fused gene and method of making and using same
FR2466251B1 (fr) * 1979-10-03 1983-03-18 Agronomique Inst Nat Rech Vaccin animal anticolibacillaire, obtention et application
US4311797A (en) * 1979-09-18 1982-01-19 University Of Saskatchewan Anucleated live E. coli vaccine
SE8001748L (sv) * 1980-03-05 1981-09-06 Kaellenius Gunilla Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik
US4454117A (en) * 1980-09-15 1984-06-12 Bactex, Inc. Immunization against infection by Escherichia coli
GB2094314A (en) * 1981-02-05 1982-09-15 Wellcome Found Recombinant DNA
WO1982003088A1 (en) * 1981-03-09 1982-09-16 Corp Cetus Vaccines
US4443431A (en) * 1981-05-27 1984-04-17 The United States Of America As Represented By The Department Of Health And Human Services Neisseria gonorrhoeae vaccine
US4443549A (en) * 1981-10-19 1984-04-17 Molecular Genetics, Inc. Production of monoclonal antibodies against bacterial adhesins
AU560262B2 (en) * 1981-10-19 1987-04-02 Molecular Genetics, Inc. Antibodies derived from hybrid line from (myeloma + antibody producing cell)
FR2516385A1 (fr) * 1981-11-19 1983-05-20 Merieux Inst Vaccin anti-aphteux et anti-colibacillaire et son procede de preparation
EP0084522A3 (de) * 1982-01-18 1983-10-19 Sandoz Ag Neue Plasmide und Bakterienstämme sowie Verfahren zu ihrer Herstellung
DK131083A (da) * 1982-03-23 1983-09-24 Svenska Sockerfabriks Ab Fremgangsmaade til fremstilling af terapeutiske eller diagnostiske praeparater
US4521334A (en) * 1982-07-27 1985-06-04 The University Of Tennesse Research Corporation Synthetic polypeptide fragments
US4597967A (en) * 1982-07-27 1986-07-01 The University Of Tennessee Research Corp. Synthetic polypeptide fragments
ZA836349B (en) * 1982-09-02 1985-04-24 Unilever Plc Production of antibodies
US4652448A (en) * 1982-10-07 1987-03-24 Molecular Genetics, Inc. Use of monoclonal antibodies against bacterial adhesins
US4736017A (en) * 1984-04-30 1988-04-05 The Board Of Trustees Of The Leland Stanford Junior University Chemically defined vaccine against urinary infections
US4801690A (en) * 1986-03-24 1989-01-31 Bactex, Inc. Novel lectins derived from bacterial pili
US4786592A (en) * 1986-06-18 1988-11-22 Scripps Clinic And Research Foundation Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin

Also Published As

Publication number Publication date
US5804198A (en) 1998-09-08
EP0179887A1 (en) 1986-05-07
JPH09183791A (ja) 1997-07-15
CA1340847C (en) 1999-12-14
DE3587468T2 (de) 1993-12-02
US4795803A (en) 1989-01-03
FI93310B (fi) 1994-12-15
DK609985A (da) 1985-12-30
IE59826B1 (en) 1994-04-06
RU1787165C (ru) 1993-01-07
EP0179887B1 (en) 1993-07-21
WO1985005037A1 (en) 1985-11-21
DK171258B1 (da) 1996-08-12
US6291649B1 (en) 2001-09-18
DK219084D0 (da) 1984-05-02
KR860700090A (ko) 1986-03-31
ATE91629T1 (de) 1993-08-15
FI860015A0 (fi) 1986-01-02
FI93310C (fi) 1995-03-27
AU4299485A (en) 1985-11-28
JPS62501355A (ja) 1987-06-04
AU593770B2 (en) 1990-02-22
IE851102L (en) 1985-11-02
JP2974028B2 (ja) 1999-11-08
FI860015A (fi) 1986-01-02
KR950000688B1 (ko) 1995-01-27
DE3587468D1 (de) 1993-08-26

Similar Documents

Publication Publication Date Title
DK609985D0 (da) Adhesin-antigener, antistoffer mod disse og dna-fragmenter, som indkoder antigenerne
DK0626447T3 (da) Monoklonale antistoffer og Fv, som er specifikke for CD2-antigen
ES2069527T3 (es) Anticuerpo quimerico especifico para el antigeno tumoral humano.
MY137300A (en) Chimeric proteins for use in transport of a selected substance into cells
FR2523445B1 (da)
ATE92336T1 (de) Monoklonale antikoerper gegen alveolares oberflaechenaktives protein.
FI964845A (fi) CD44v6:n vastaiset monoklonaaliset vasta-aineet
DK304087A (da) Humant monoklonalt antistof mod lumfadenopati-associeret virus
ES553757A0 (es) Un metodo para preparar proteinas que son inmunologicamente reactivas con anticuerpos para virus asociados con linfadenopatia
EP0151320A3 (en) Pure alkaline phosphatase, its preparation and use
ATE16406T1 (de) Verfahren zur herstellung von isomaltulose (6-o- alpha-d-gluco-pyranosido-d-fructose) mit hilfe von immobilisierten bakterienzellen.
NO843591L (no) Fremgangsmaate for aa bestemme pivka-ii-innhold i blodplasma og middel for utfoerelse av denne
DK369287D0 (da) Immunotoksiner og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende dem
KR900004935A (ko) 슈도 모나즈 아에루기노사의 지질단백질 i(ompi)
ES2179824T3 (es) Anticuerpos humanizados reactivos contra el antigeno gpiib/iiia.
ATE134874T1 (de) Synoviale phospholipasen
ES2061719T3 (es) Proceso para la produccion de proteinas.
ATE103989T1 (de) Monoklonale antikoerper gegen e7-protein des humanen papillomvirus typ 16, verfahren zu ihrer herstellung sowie ihre verwendung.
EP0338395A3 (en) Monoclonal antibodies to pseudomonas aeruginosa, their production and use
ATE58397T1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
KR890002402A (ko) 인간의 유두종바이러스형 41, 이의 dna 및 이로부터 코드화된 단백질
DE3579808D1 (de) Anti-urokinase monoklonaler antikoerper, seine herstellung und verwendung.
JPS5386014A (en) Quantitative analysis of antigen and antibody
IT8421612A0 (it) Vettore clonante, procedimento per la sua costruzione e procedimentodi concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante.
KR960006941A (ko) 인간 혈중 아포지단백질(apolipoprotein) A-I에 대한 신규 단일클론 항체 및 이들의 생산을 위한 재조합 하이브리도마 세포주

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired